A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial

NCT00810589 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diabetes, Type I

Interventions

DRUG: Levemir
DRUG: Humalog NPL Insulin

Sponsor

Medical University of Graz